Editorial
doi: 10.1001/jama.295.13.jed60020.
Epub 2006 Mar 14.
Fondaparinux in ST-segment elevation myocardial infarction: the drug, the strategy, the environment, or all of the above?
- PMID: 16537724
- DOI: 10.1001/jama.295.13.jed60020
Item in Clipboard
Editorial
Fondaparinux in ST-segment elevation myocardial infarction: the drug, the strategy, the environment, or all of the above?
JAMA.
.
No abstract available
Comment on
-
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.JAMA. 2006 Apr 5;295(13):1519-30. doi: 10.1001/jama.295.13.joc60038. Epub 2006 Mar 14. JAMA. 2006. PMID: 16537725 Clinical Trial.
Similar articles
-
Fondaparinux in patients with ST-segment elevation myocardial infarction.JAMA. 2006 Nov 1;296(17):2087; author reply 2088-9. doi: 10.1001/jama.296.17.2087-a. JAMA. 2006. PMID: 17077369 No abstract available.
-
Fondaparinux in patients with ST-segment elevation myocardial infarction.JAMA. 2006 Nov 1;296(17):2087-8; author reply 2088-9. doi: 10.1001/jama.296.17.2087-b. JAMA. 2006. PMID: 17077368 No abstract available.
-
Fondaparinux in patients with ST-segment elevation myocardial infarction.JAMA. 2006 Nov 1;296(17):2088; author reply 2088-9. doi: 10.1001/jama.296.17.2088-a. JAMA. 2006. PMID: 17077370 No abstract available.
-
Fondaparinux: pharmacology and clinical experience in cardiovascular medicine.Mini Rev Med Chem. 2007 Apr;7(4):383-7. doi: 10.2174/138955707780363819. Mini Rev Med Chem. 2007. PMID: 17430224 Review.
-
Fondaparinux in Acute Coronary Syndromes.J Assoc Physicians India. 2015 Jul;63(7):83-7. J Assoc Physicians India. 2015. PMID: 26731838 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
